Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma

Tumor mutation burden (TMB) is a useful biomarker to predict prognosis and the efficacy of immune checkpoint inhibitors (ICIs). In this study, we aimed to explore the prognostic value of TMB and the potential association between TMB and immune infiltration in lower-grade gliomas (LGGs). Somatic muta...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Oncol
मुख्य लेखकों: Yin, Wen, Jiang, Xingjun, Tan, Jun, Xin, Zhaoqi, Zhou, Quanwei, Zhan, Chaohong, Fu, Xianyong, Wu, Zhaoping, Guo, Youwei, Jiang, Zhipeng, Ren, Caiping, Tang, Guihua
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2020
विषय:
Oncology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7468526/
https://ncbi.nlm.nih.gov/pubmed/32974146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01409
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन